IDH1 and astrocytoma (excluding glioblastoma): On the other hand, homozygous CDKN2A/B deletion in diffuse IDH-mutant astrocytomas is a sufficient prerequisite for assigning it to grade IV, irrespective of the presence or absence of malignant histology [6].